Bruno

Led laboratory components of global clinical trials ( Americas, EMEA, APAC) as primary point of contact, coordinating internal teams (laboratory, data management, warehouse, quality, legal, finance, scientific).

Oversaw risk mitigation, timelines, budgets, vendor management, and quality compliance (ICH- GCP).

Maintained customer-centric focus, ensuring alignment with client expectations and sponsor milestones.

Represented the company in audits and client meetings, mentored and onboarded junior PMs, enabling smoother team integration.

Outcome: Managed up to seven global studies simultaneously, supported Phase I and II protocols in diverse therapeutic areas (Oncology, Immunology, Metabolic Diseases, among others), improved sponsor relationships contributing to portfolio expansion, and supported the Emerging BioPharma (EBP) segment.

onfigured and validated lab databases for global trials, acting as escalation point for technical issues.

Enabled tailored database solutions across cross-functional teams, ensuring accuracy and timely delivery.

Facilitated onboarding and knowledge transfer to strengthen operational capacity.

Outcome: Optimized data integrity and contributed to smoother study start-up cycles across LATAM and global operations.

irected phage-based therapeutic projects from lab design to field trials in a biotech startup.

Designed literature-driven experimental roadmaps and engaged in peer-to-peer scientific discussions to evaluate project feasibility.

Identified critical market needs and defined feasible experimental roadmaps.

Coordinated with production partners to advance product validation and early development.

Outcome: Established viable pipelines for 4 novel phage therapeutic formulations, bridging R&D to market readiness through go-to-market strategies and data-driven approaches.